440 filings
Page 8 of 22
UPLOAD
qrd4l 9iki
17 Jun 20
Letter from SEC
12:00am
8-K
emncn0
16 Jun 20
Departure of Directors or Certain Officers
5:27pm
S-8
wdoc 9z36z
16 Jun 20
Registration of securities for employees
4:52pm
POS AM
agw20iqx
8 Jun 20
Prospectus update (post-effective amendment)
12:00am
8-K
dtxt202moetp 40
4 Jun 20
AcelRx Pharmaceuticals Announces It Will Not Further Revise Its Offer to Acquire Tetraphase
4:05pm
8-K
u8u4ojvzud
29 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:12pm
425
7by 6grrz1bv40yc
29 May 20
Business combination disclosure
5:10pm
425
4d2wg6k
29 May 20
Business combination disclosure
8:54am
8-K
s8v25eb8kic1kp0wy87
27 May 20
AcelRx Pharmaceuticals Announces Revised Merger Agreement with Tetraphase
5:03pm
425
xyp75p
27 May 20
Business combination disclosure
5:01pm
425
g7v2sa7
27 May 20
Business combination disclosure
9:29am
8-K
ipmey
22 May 20
Termination of a Material Definitive Agreement
4:11pm
425
70j154w8ehh2twqu p8c
12 May 20
Business combination disclosure
4:10pm
425
2zt1fc4d1o07xqp
11 May 20
Business combination disclosure
4:06pm
8-K
4stld5 61rl7z
11 May 20
AcelRx Pharmaceuticals Reports First Quarter 2020 Financial Results
4:05pm
8-K
7zbbxdd
30 Apr 20
AcelRx Announces DSUVIA® Milestone C Approval
8:24am
425
2avinay0ywmej
30 Apr 20
Business combination disclosure
8:22am
EFFECT
arhlw5kc
27 Apr 20
Notice of effectiveness
12:15am